Checkpoint Therapeutics Inc
F:CZTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Checkpoint Therapeutics Inc
F:CZTA
|
US |
|
G
|
Genmab A/S
F:GE9
|
DK |
|
Barnes & Noble Education Inc
F:2BN0
|
US |
|
Remitly Global Inc
NASDAQ:RELY
|
US |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
Prada SpA
OTC:PRDSF
|
IT |
|
D
|
Drone Delivery Canada Corp
F:ABB
|
CA |
|
Fagerhult AB
F:2F0
|
SE |
|
I
|
Innergex Renewable Energy Inc
XBER:3IX
|
CA |
|
S
|
SFC Energy AG
XBER:F3C
|
DE |
|
Orezone Gold Corp
F:OEX
|
CA |
|
Hindustan Construction Company Ltd
NSE:HCC
|
IN |
|
Metropolitan Bank and Trust Co
OTC:MTPOF
|
PH |
|
T
|
Ta Liang Technology Co Ltd
TWSE:3167
|
TW |
|
A
|
Abacus Mining and Exploration Corp
OTC:ABCFF
|
CA |
|
E
|
Edison International
SWB:EIX
|
US |
|
T
|
T Rowe Price Group Inc
SWB:TR1
|
US |
|
PSI Software AG
F:PSAN
|
DE |
Wall St Price Targets
CZTA Price Targets Summary
Checkpoint Therapeutics Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CZTA's stock price target?
Not Available
CZTA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Checkpoint Therapeutics Inc?
Projected CAGR
247%
Over the last 8 years, the compound annual growth rate for Revenue has been -40%. The projected CAGR for the next 8 years is 247%.